CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.90 -0.01 (-1.33%)
As of: Oct 22, 2026 · 3:28 PM EDT

CytoMed Therapeutics (GDTC) Enterprise Value (2023 - 2026)

Updated

CytoMed Therapeutics' Enterprise Value was $11.15 million in Q2 2026, down 47.8% from $21.34 million a year earlier.

Analysis

CytoMed Therapeutics (GDTC) Enterprise Value (2023 - 2026) Analysis & Trends

On a trailing twelve-month basis, CytoMed Therapeutics' Enterprise Value was $1.1 million through Jun 30, 2026, down 43.5% year-over-year; for FY2025, it was $14.56 million, down 59.1% from FY2024.

  • In earlier years, Enterprise Value was $35.59 million in FY2024 (-28.6%) and $49.85 million in FY2023.
  • Compared with a year earlier, Enterprise Value was higher in 1 of the last four quarters, with an average decline of 23.3%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,170.46 Bn 1,139.04 Bn 19.71 Bn
2 Johnson & Johnson 648.38 Bn 568.24 Bn 17.30 Bn
3 AbbVie 504.43 Bn 477.54 Bn 12.70 Bn
4 Merck 367.73 Bn 322.11 Bn 12.21 Bn
5 Novartis Ag 303.35 Bn 267.34 Bn 11.24 Bn
6 Astrazeneca 268.20 Bn 241.88 Bn 12.86 Bn
7 Amgen 242.55 Bn 197.95 Bn 7.24 Bn
8 Gilead Sciences 194.80 Bn 169.00 Bn 6.22 Bn
9 Pfizer 173.31 Bn 119.95 Bn 10.94 Bn
10 CytoMed Therapeutics 10.46 Mn 855,548.76 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.15 Mn
Dec 31, 2025 14.53 Mn
Jun 30, 2025 23.19 Mn
Dec 31, 2024 35.66 Mn
Jun 30, 2024 17.53 Mn
Dec 31, 2023 49.73 Mn
Jun 30, 2023 13.70 Mn
API Access

CytoMed Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=GDTC&period=max&api_key=YOUR_API_KEY